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1. Introduction
  Carotid pseudoaneurysms (CP) are infrequent lesions[1]. 
Etiology includes previous carotid surgery, trauma, 
infection, cancer or immune disorders[2,3]. Carotid redo 
conventional surgery in the previously operated neck, 
as well as after radiation therapy, are both technically 
demanding and prone to increased rates of complications 
especially for stroke, nerve damage and wound infection 
even in renown centres[4].
  In these circumstances, endovascular techniques 
developed as a valid alternative; periodically, encouraging 
results have been reported in several case reports 
especially for carotid endarterectomy related (CEA-related) 
pseudoaneurysms[5-18].
   We present the case of a post-endarterectomy huge CP 
managed with stent-graft (SG).
2. Case report
  He is a 76-year-old male; medical history was remarkable 
for tobacco abuse and hypertension, radiation and 
thyroidectomy for cancer, and a left carotid endarterectomy 
(CEA) plus dacron patch closure for a transient ischemic 
attack (TIA) performed twenty-five years before the actual 
admission. Over the years, he did not receive regular 
follow-up examination with echo-color-Doppler, but a 
recent carotid ultrasound showed a huge CP as well as 
an 80% re-stenosis at the proximal aspect of the internal 
carotid artery. A computed-tomography angiography was 
performed, showing a type 1 aortic arch with a bovine 
configuration, and confirmed the presence of a 35 mm 伊 
40 mm CP with no blood extravasations or radiologic signs 
of infection (Figure 1). From a clinical point o view, he 
denied fever and local signs of infection (skin changes, 
erythema) were absent. Leukocytes count (7 850 cells/
mm3) was in the normal range (4.3-11 000 cells/mm3), and 
blood cultures were negative for bacteria: therefore, we 
excluded the diagnosis of an infected patch and concluded 
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for a pseudoaneurysm dilation. Open repair was particularly 
challenging because of the previous repeated neck surgery 
as well as radiation therapy. We proposed an endovascular 
repair, and the informed consent was obtained. In the 
angiographic suite, under intravenous sedation and local 
anaesthesia a percutaneous right femoral artery approach 
was attempted first. The patient was given 70 IU/kg of 
heparin intravenously prior to manipulation of the arch 
vessels, and activated clotting time was maintained >275 
s. Selective left carotid hiring was not successful from the 
transfemoral route; hence, we decided to use a percutaneous 
right brachial to better address the bovine configuration of 
the aortic arch. A direct cervical incision was not thought 
to be reasonable because of the presence of the extensive 
cervical scar as well as previous radiation treatment. An 
hydrophilic stiff-angled guidewire (Radiofocus襆-Terumo 
Corp.; Somerset-NJ; USA) was used to obtain access to 
the external carotid artery; a long multipurpose catheter 
(Brite Tip襆-Cordis J&J-Waterloo; Belgium) allowed 
a wire exchange for a 0.035-inch wire (SuperCore襆
- Guidant; Santa Clara襆-CA; USA). An 8Fr for 65 cm 
long sheath (Avanti襆-Cordis J&J-Waterloo; Belgium) 
was advanced just proximal to the common carotid artery 
stenosis and a cerebral protection device (Epi Filter EZ襆
-Boston Scientific; Natick-MS; USA) was positioned. Two 
heparin-bonded ePTFE SGs (Viabahn襆-W.L. Gore & Ass.; 
Flagstaff-AZ; USA) were deployed using the telescope 
technique (distal first: 6 mm 伊 5 cm, then proximal 8 
mm 伊 10 cm) and gently post-dilated to correct the focal 
stenosis at the common carotid artery. Final angiogram with 
cerebral study confirmed the complete exclusion of the CP 
with efficient flow into the internal carotid artery (Figure 
2). Brachial and femoral accesses were closed with hand 
compression. The postoperative course was complicated: an 
expanding hematoma was observed at both percutaneous 
accesses. Conventional repair was required: a reversed 
saphenous vein graft was used to repair a dissecting flap 
of the brachial artery, whereas a primary suture was used 
to correct the defect of the femoral artery. The subsequent 
postoperative course was uneventful; he was discharged 
on day 6th postoperatively, and clopidogrel 75 mg (Plavix襆
- Bristol-Myers Squibb/Sanofi Pharmaceuticals; New York 
-NY; USA) plus acetylsalicylic acid 100 mg (Cardioaspirin
襆-Bayer; Milano-IT) were started on a daily basis, ad 
infinitum. He was last seen 12 months after the procedure, 
asymptomatic: both the echo-color-Doppler and the CT-A 
showed the persistent exclusion of the CP, the shrinkage 
(7 mm) of the sac, the patency of the SGs without signs of 
endoleak or edge stenoses.
LICA
LCCA
 
Figure 1. Preoperative CT-A: bovine arch configuration (A, square) 
and pseudoaneurysm (arrow) involving the whole patch. Multiplanar 
reconstruction (B) detailing the stenosis (ring) at the proximal aspect 
of the patch on the common carotid, and the take-off of the external 
carotid artery (lines).
=
Figure 2.  Intraoperative angiography: selective study (A) of the 
pseudoaneurysm, and final control after SG deployment (B) with the 
complete exclusion of the lesion.
3. Discussion
  Carotid endarterectomy-related pseudoaneurysm is 
rare complication (less than 1% of all CEA) but the most 
frequently reported aneurysm of the extracranial carotid 
arteries[2,3,5]. Although the formation of the CP after patch 
angioplasty has been reported twice as common compared 
to primary closure, others have found a 0.33% incidence 
after patch angioplasty vs. 0.25% following primary closure, 
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a difference that is not statistically significant[1]. The most 
extensive series of CEA-related CPs has been published 
by El-Sabrout and Cooley[3] who reported a 57% incidence 
out of their 67 cases: in their data, patch closure was the 
dominant method of reconstruction.
  The cause of our CP was undetermined. The pathogenesis 
of non infected CEA-related CPs may have different 
pathogeneses: rupture or dilatation of patch material, partial 
disruption of the suture line due to infection, or mechanical 
stress[3]. A recent review of Bond et al[19]. concluded that 
up to now there is no evidence to support the advantage 
of vein over synthetic patch material after CEA, but if 
synthetic material is selected, the available data appears to 
show benefits from PTFE as opposed to Dacron material. 
Because it occurred 25-years after the initial surgery, 
structural dilation of the entire Dacron patch have been 
considered a plausible cause. In the present brief review 
of CPs managed with SGs, we were unable to identify the 
type of reconstruction in 13% of the cases: nevertheless, 
in the reminder cases, we observed that 47% developed 
over a Dacron patch and 20% after vein patch (e.g. having 
superinfection in one case each), and no ePTFE patch 
dilation was reported.
  Clinical onset of the CEA-related CPs is very 
heterogeneous in terms of delay from the original 
intervention: out of the 6/14 (43%) cases that developed 
within the first year, mean delay was 4 months vs. the mean 
12 years of those presenting in the long run. Regardless the 
time of onset, an expanding pulsatile mass, together with 
related compressive symptoms, was the leading sign for 
medical alertness in both groups; cerebrovascular symptoms 
was observed in 1 case only. 
  Just cerebrovascular symptoms probably from thrombosis 
or embolism and the potential for possible rupture or 
fistulization should be considered reasonable indication for 
repair[1-5]. Before the advent of endovascular techniques, 
conventional surgery was the only modality to treat these 
lesions[2-4]. Even in the most renown centers, operative 
morbidity and mortality remained high: considering only 
the CPs, El-Sabrout et al[2]. reported and overall incidence 
of early mortality/major stroke of 10.8%, and only 13 
(35.1%) patients remained asymptomatic without further 
interventions and showed no recurrence. Similarly, Hertzer 
et al[4]. had stroke, graft thrombosis, and a high incidence 
of cranial nerve injury (44%). More recently, endovascular 
repair has gained wide interest: the benefits of this approach 
include the avoidance of a hostile operative field, lack of 
risk of nerve injury, and accessibility of the high internal 
carotid artery[2]. Stent-graft repair of the pseudoaneurysm 
was weighted as the best approach for managing our case, 
because we had a large pseudoaneurysm that extended 
to the base of the neck requiring difficult proximal and 
distal vessels control. Even stent-grafting is not free of 
complication: in our review, we identified 1 (6.6%) death as 
a consequence of an acute myocardial infarction that was 
not possible to treat due to patient refusal, 2 (14.3%) access 
complications that required surgery, and further 2 (14.3%) 
cerebrovascular accidents that had no sequelae. However, to 
tell the truth, all the patients who were discharged alive are 
still doing well with no recurrent lesions (Table 1).
  Carotid artery stenting is generally performed without 
cerebral protection for CEA-related re-stenosis or closure 
complication: the main source of embolization have been 
removed and re-stenoses are mainly an hyperplastic 
process[20,21]. We believe that in case of a CP distal 
embolization can still remain a threatening concern: in 
fact, sac thrombosis may generate emboli. This is the main 
reason why we used a protective filter; despite this, we 
noted that in the 15 cases we compiled in this brief review, 
filter protection has not been used ever. Filter protection 
should be a matter of debate: Martin et al[14]. clearly stated 
that unlike atherosclerotic occlusive disease, treatment 
of an aneurysm did not appear to cause an immediate 
intraoperative threat because a well-organized thrombus 
should carry less risk of distal embolization. Also McCready 
et al[12]. did not use filter to protect against embolization 
but after having had cerebrovascular complications their 
conclusive suggestion was to support cerebral protection 
devices with large CPs, even if were not able to substantiate 
recommendation. One potential alternative technique to 
prevent peripheral embolization could be a direct carotid 
artery access to circumvent the need to manipulate catheters 
through the aortic arch or filter devices. This approach 
has been suggested by Ahujia et al[15]. who described this 
approach to be more advantageous because the proximal 
aspect of the common carotid can be clamped during 
the stenting maneuvers, thereby minimizing the risk of 
embolization.
  Endovascular treatments for CEA-related CPs have been 
already described with stent: Bush et al[22]. treated 2 cases 
of CP with stenting plus coils placed into the sac via the 
interstices. Alarmingly, a TIA was recorded few days after 
the procedure, specifically after a re-stenting procedure to 
correct an extremity stenosis. No details have been offered 
to the readers about that; it is difficult to think about a coil 
dislodgment, rather the friable thrombus inside the CP may 
have protruded into the endoluminal surface and may have 
been the source of emboli. The use of a SG could prevent 
either the risks of imprecise placement of coils or thrombotic 
embolization into the cerebral circulation. In addition, SG 
could also prevent a potential injury caused by a bare-metal 
stent: even if anecdotal, 2 cases of CP have been reported 
following carotid stenting.
  Different devices have been reported in literature to 
be used: the advent of self-expanding device was an 
improvement over balloon-expandable because of their 
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flexibility in conforming to tortuous segments, and because 
they easily accommodate varying diameters of the carotid 
arteries, especially at the transition from the common to 
the internal carotid[5,23].  In addition, a self-expanding 
stent is safer than a balloon-mounted stent because of 
potential arterial injury resulting from high balloon inflation 
pressures needed for stent deployment. The porosity and 
inflammatory nature of the Dacron covered SGs made it 
not ideal: Terramani et al[9]. reported the need to drain a 
persisting hematoma causing compressive symptoms fed 
by the porosity of the SG. In order to avoid this drawback, 
we preferred to use a more recent ePTFE device that have 
been optimized with technical and chemical aspects: 
the contoured edge as well as the heparin-bonded inner 
surface of the new Viabahn® was exploited to have better 
hemodynamic into the distal internal carotid artery and to 
prevent against stent re-stenosis.
  Another interesting technical aspect to be discussed could 
be the need to exclude the external carotid artery. It has 
been suggested that if the external carotid artery arises in the 
vicinity of the pseudoaneurysm, it could be necessary to first 
embolize it with coils prior to SG placement, otherwise it will 
become a source of endoleak which may lead to subsequent 
pseudoaneurysm expansion[7,13,14]. This procedure could be 
offset by the risks of sequelae that include facial weakness 
and exertional pain associated with chewing. Reviewing the 
15 cases we have identified we agree with most of them that 
did not perform preventive external carotid embolization. 
Table 1
CEA-related carotid pseudoaneurysm treated with stent-graft.
Author, yr Cases
(n)
Age
(year)
Gender
 
Intervention Onset
(months)
Signs/
symptoms
 
Sizing
( mm)
Infection Stent-graft Devices
(number)
Filter
 
Complication
(type)
LOS
(days)
Therapy
(type)
Follow-
up
(months)
Outcome
 
Patency
 
Shrinkage
 
Recurr-
ency
 
May, 1997 1 70 M right CEA + 
n.r.
264 neck
 swelling
3 0 伊 
30
no Passager® 1 no minor stroke 7 Warfarin 6 alive yes yes no
Lin, 2003 1 74 M right CEA + 
pericardial 
patch
24 neck pain +
expanding
 mass
5 0 伊 
60
no Wallgraft® 1 no uneventful n.r. n.r. 18 alive yes yes  
Hertz,
 2003
1 80 M right CEA + 
pericardial 
patch
30 neck pain + 
skin changes
42 no Wallgraft® 2 no A M I  ( 1 s t 
p.op.)
6  0 dead    
Terramani, 
2003
1 82 M right CEA + 
dacron patch
1 expanding 
mass
41 伊 
36
no Wallgraft® 2 no hematoma n.r. n.r. 8 alive yes yes no
G u p t a  K , 
2004
1 72 M right CEA + 
dacron patch
48 expanding 
mass
60 伊 
40
no Viabahn® 1 no uneventful n.r. Clopidogrel 
+ 
ASA
6 alive yes yes no
Baril,
 2004
1 79 F right CEA + 
dacron patch
132 TIA n.r. yes Viabahn® 1 no uneventful n.r. Clopidogrel 
+ 
ASA
12 alive yes yes no
McCready, 
2004
1 58 M right CEA 
+ Surgisis 
patch
1 neck 
fullness
n.r. no Wallgraft® 2 no TIA n.r. Clopidogrel 12 alive no yes no
Mousa,
 2005
1 82 F right CEA + 
dacron patch
24 headache+
expanding 
mass
35 伊 
30
no Wallgraft® 
+
ECA coils
1 no uneventful 2 n.r. 6 alive yes yes no
Martin,
 2005
1 68 M right CEA + 
vein patch
204 expanding 
mass
60 伊 
25
no Viabahn® 
+
ECA coils
2 no uneventful n.r. Clopidogrel 
+ 
ASA
3 alive yes n.r. no
Ahuja,
 2007
2 70 M left CEA + 
vein patch
240 expanding
mass
63 伊 
53
no Viabahn® 3 no uneventful n.r. Clopidogrel 
+ 
ASA
18 alive yes yes no
  86 F left CEA + 
vein patch
2 expanding
mass
23 伊 
19
yes Viabahn® 2 no uneventful n.r. n.r. 12 alive yes n.r. no
B r i g u o r i , 
2007
1 76 M left CEA + 
dacron patch
7 follow-up
finding
15 伊 
10
no Fluency® 1 no uneventful 2 n.r. 3 alive yes n.r. no
G u p t a  R , 
2008
1 87 M right CEA + 
n.r.
12 neck pain +
hoarness
80 伊 
60
no Wallgraft® 1 no uneventful n.r. ASA 3 alive yes yes no
Troutman, 
2010
1 66 M left CEA + 
dacron patch
3 neck pain +
expanding 
mass
20 伊 
20
no Wallgraft® 2 no uneventful 1 Clopidogrel 108 alive yes yes no
Present,
 2011
1 76 M left CEA + 
dacron patch
300 asymptomatic 35 伊 
40
no Viabahn® 2 no arm ischemia 
(1st p.op.)
6 Clopidogrel 
+ ASA
12 alive yes yes no
Total 15 758   86113          1627     
n.r. = not reported; CEA = carotid endarterectomy; LOS = length of stay; TIA = transitory ischemic attack; ASA = acetlysalicilic acid.
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Anatomical details of the external carotid artery take-
off was not always specified: nevertheless, in all the 12 
cases that did not perform embolization and used direct SG 
simply, no recurrency has been detected at a mean follow-
up of 1 year and a half. Even if long-term results in the 
published literature is still lacking, simply because these 
devices have only been available in the past few years, SG 
management for CEA-related CPs seems to be a viable and 
effective treatment option with better results.
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